Medcura earns an Innovative Device designation for its LifeGel™ Absorption Hemostatic Surgical Device

College Park, Maryland.And January 12, 2023 /PRNewswire/ –Medcura, Inc. announces: Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, today announced that the U.S. Food and Drug Administration (FDA) has awarded the Prestigious Device Innovator Designation to LifeGel™ Absorbable Surgical Hemostat. LifeGel™ is the first and only hemostatic agent to … Read more